FTO negatively regulates the cytotoxic activity of natural killer cells

Cited 26 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorSeok-Min Kim-
dc.contributor.authorSe-Chan Oh-
dc.contributor.authorSun-Young Lee-
dc.contributor.authorLing-Zu Kong-
dc.contributor.authorJ H Lee-
dc.contributor.authorTae-Don Kim-
dc.date.accessioned2023-04-10T16:33:53Z-
dc.date.available2023-04-10T16:33:53Z-
dc.date.issued2023-
dc.identifier.issn1469-221X-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/31579-
dc.description.abstractN6 -Methyladenosine (m6 A) is the most abundant epitranscriptomic mark and plays a fundamental role in almost every aspect of mRNA metabolism. Although m6 A writers and readers have been widely studied, the roles of m6 A erasers are not well-understood. Here, we investigate the role of FTO, one of the m6 A erasers, in natural killer (NK) cell immunity. We observe that FTO-deficient NK cells are hyperactivated. Fto knockout (Fto-/- ) mouse NK cells prevent melanoma metastasis in vivo, and FTO-deficient human NK cells enhance the antitumor response against leukemia in vitro. We find that FTO negatively regulates IL-2/15-driven JAK/STAT signaling by increasing the mRNA stability of suppressor of cytokine signaling protein (SOCS) family genes. Our results suggest that FTO is an essential modulator of NK cell immunity, providing a new immunotherapeutic strategy for allogeneic NK cell therapies.-
dc.publisherWiley-
dc.titleFTO negatively regulates the cytotoxic activity of natural killer cells-
dc.title.alternativeFTO negatively regulates the cytotoxic activity of natural killer cells-
dc.typeArticle-
dc.citation.titleEMBO Reports-
dc.citation.number4-
dc.citation.endPagee55681-
dc.citation.startPagee55681-
dc.citation.volume24-
dc.contributor.affiliatedAuthorSeok-Min Kim-
dc.contributor.affiliatedAuthorSe-Chan Oh-
dc.contributor.affiliatedAuthorSun-Young Lee-
dc.contributor.affiliatedAuthorLing-Zu Kong-
dc.contributor.affiliatedAuthorTae-Don Kim-
dc.contributor.alternativeName김석민-
dc.contributor.alternativeName오세찬-
dc.contributor.alternativeName이선영-
dc.contributor.alternativeName공링주-
dc.contributor.alternativeName이종희-
dc.contributor.alternativeName김태돈-
dc.identifier.bibliographicCitationEMBO Reports, vol. 24, no. 4, pp. e55681-e55681-
dc.identifier.doi10.15252/embr.202255681-
dc.subject.keywordEpitranscriptome-
dc.subject.keywordFTO-
dc.subject.keywordm6A regulator-
dc.subject.keywordN6-methyladenosine-
dc.subject.keywordNK cell-
dc.subject.localFTO-
dc.subject.localN6-methyladenosine-
dc.subject.localNK cell-
dc.subject.localNK cells-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Immunotherapy Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.